(JREM) JPMorgan s (Ireland) ICAV - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BF4G6Z54

JREM: Emerging Markets, ESG, Equity, Diversification, UCITS, ETF, Exposure

Objective: The JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enhanced Index Eq (ESG) UCITS ETF USD Acc (Ticker: JREM) is designed to provide exposure to emerging markets equities with an ESG focus. Listed on XETRA, this ETF tracks the Morningstar EM TME NR USD index, offering a diversified portfolio of emerging market stocks. The fund is structured as an Irish ICAV and distributes dividends in USD accumulation shares.

3-Month Forecast: Based on and , the ETF is expected to remain stable with potential for modest growth. The SMA 20 (27.25) and SMA 50 (28.92) indicate a recent uptrend, while the SMA 200 (29.01) suggests long-term stability. The ATR of 0.58 signals low volatility. With an AUM of 1,254.91M EUR, the fund benefits from scale, which supports liquidity. Average daily volume of 6,630 shares suggests moderate trading activity. The last price of 28.78 aligns closely with the SMA 50, indicating a balanced technical outlook. Fundamental strength in emerging markets, driven by improving economic indicators and ESG adoption, is expected to support performance over the next quarter.

Additional Details: As part of the Global Emerging Markets Equity category, JREM provides access to a broad range of emerging market equities, focusing on companies that meet ESG criteria. The funds ESG framework aims to enhance returns while aligning with sustainable investing principles. The Morningstar EM TME NR USD index serves as the benchmark, ensuring the ETF reflects the performance of its target market. JREM is incorporated in Ireland and is denominated in USD, making it accessible to international investors seeking emerging market exposure with a focus on sustainability.

Additional Sources for JREM ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

JREM ETF Overview

Market Cap in USD 1,410m
Category Global Emerging Markets Equity
IPO / Inception 2018-12-05

JREM ETF Ratings

Growth Rating 20.5
Fundamental -
Dividend Rating 0.0
Rel. Strength -18.2
Analysts -
Fair Price Momentum 25.92 EUR
Fair Price DCF -

JREM Dividends

Currently no dividends paid

JREM Growth Ratios

Growth Correlation 3m -12.3%
Growth Correlation 12m 41.1%
Growth Correlation 5y 7.1%
CAGR 5y 5.08%
CAGR/Max DD 5y 0.18
Sharpe Ratio 12m 0.50
Alpha -2.58
Beta 0.618
Volatility 14.22%
Current Volume 2.9k
Average Volume 20d 6k
What is the price of JREM shares?
As of June 01, 2025, the stock is trading at EUR 29.15 with a total of 2,887 shares traded.
Over the past week, the price has changed by -1.59%, over one month by +4.82%, over three months by -5.45% and over the past year by +5.64%.
Is JPMorgan s (Ireland) ICAV a good stock to buy?
Neither. Based on ValueRay´s Analyses, JPMorgan s (Ireland) ICAV is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 20.53 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JREM is around 25.92 EUR . This means that JREM is currently overvalued and has a potential downside of -11.08%.
Is JREM a buy, sell or hold?
JPMorgan s (Ireland) ICAV has no consensus analysts rating.
What are the forecasts for JREM share price target?
According to our own proprietary Forecast Model, JREM JPMorgan s (Ireland) ICAV will be worth about 29.4 in June 2026. The stock is currently trading at 29.15. This means that the stock has a potential upside of +0.75%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 29.4 0.8%